SPACCAROTELLA, CARMEN ANNA MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.275
EU - Europa 2.471
NA - Nord America 1.640
SA - Sud America 474
AF - Africa 109
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.998
Nazione #
SG - Singapore 1.775
US - Stati Uniti d'America 1.572
RU - Federazione Russa 1.203
CN - Cina 579
BR - Brasile 388
HK - Hong Kong 376
IT - Italia 361
DE - Germania 289
NL - Olanda 258
VN - Vietnam 234
GB - Regno Unito 87
IN - India 72
UA - Ucraina 53
KR - Corea 52
AR - Argentina 42
FI - Finlandia 30
MX - Messico 30
CI - Costa d'Avorio 29
ID - Indonesia 27
AT - Austria 26
FR - Francia 26
BD - Bangladesh 24
PL - Polonia 24
CA - Canada 23
TR - Turchia 22
AU - Australia 21
IE - Irlanda 19
EC - Ecuador 18
BG - Bulgaria 16
ES - Italia 15
IQ - Iraq 15
ZA - Sudafrica 15
IR - Iran 13
EG - Egitto 12
SE - Svezia 12
MA - Marocco 11
MY - Malesia 11
CH - Svizzera 10
CO - Colombia 9
ET - Etiopia 9
GR - Grecia 9
AE - Emirati Arabi Uniti 7
JP - Giappone 7
PK - Pakistan 7
SA - Arabia Saudita 7
KE - Kenya 6
LY - Libia 6
JO - Giordania 5
LT - Lituania 5
TH - Thailandia 5
TN - Tunisia 5
CL - Cile 4
CZ - Repubblica Ceca 4
LB - Libano 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
A1 - Anonimo 3
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
PE - Perù 3
UY - Uruguay 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BJ - Benin 2
BN - Brunei Darussalam 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
MR - Mauritania 2
NE - Niger 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VE - Venezuela 2
YE - Yemen 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GM - Gambi 1
HN - Honduras 1
HT - Haiti 1
Totale 7.982
Città #
Singapore 863
Hong Kong 369
Moscow 264
Hefei 241
Amsterdam 217
Santa Clara 183
Beijing 146
Ashburn 129
Millbury 126
Chandler 115
Naples 115
Lawrence 92
Ho Chi Minh City 75
Los Angeles 60
Hanoi 52
Redondo Beach 46
Seoul 45
Buffalo 43
Krefeld 37
Wilmington 36
Munich 34
New York 29
São Paulo 24
Nuremberg 22
Rome 21
Seattle 21
The Dalles 21
Dallas 17
Frankfurt am Main 17
Rio de Janeiro 17
Mexico City 16
Sofia 16
Bad Durrheim 15
Dublin 15
Fairfield 15
Warsaw 15
Lappeenranta 14
Vienna 13
Montreal 12
Boston 11
Milan 11
Belo Horizonte 10
Brooklyn 10
Cairo 10
Denver 10
Haiphong 10
Prineville 10
Stockholm 10
Turku 10
Athens 9
Bologna 9
Chicago 9
Sydney 9
Turin 9
Atlanta 8
Bengaluru 8
Buenos Aires 8
Hanover 8
Kronberg 8
Addis Ababa 7
Curitiba 7
Johannesburg 7
Orem 7
Padova 7
Poplar 7
Brasília 6
Chennai 6
Dhaka 6
Guayaquil 6
Ha Long 6
Manchester 6
Nairobi 6
Quito 6
San Jose 6
Amman 5
Biên Hòa 5
Hangzhou 5
Helsinki 5
Hải Dương 5
London 5
Osasco 5
Perth 5
Phoenix 5
Phủ Lý 5
Recife 5
Rochdale 5
Salt Lake City 5
São José do Rio Preto 5
Tripoli 5
Boardman 4
Bắc Ninh 4
Casablanca 4
Catanzaro 4
Columbus 4
Da Nang 4
Düsseldorf 4
Erbil 4
Houston 4
Istanbul 4
Kochi 4
Totale 4.010
Nome #
European Society of Cardiology: cardiovascular disease statistics 2021 396
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 219
Edoxaban (LIXIANA®) in the treatment of venous thromboembolism 201
Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection 141
Diagnosi e Terapia in Unità Coronaria ed Emodinamica 132
[ANMCO/SIC/SICI-GISE/SICCH Consensus document: Risk stratification in elderly patients undergoing cardiac surgery and transcatheter aortic valve implantation] 123
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease) 113
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 107
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 105
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 100
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology 97
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 95
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 94
Recommendations in pre-procedural imaging assessment for TAVI intervention: SIC-SIRM position paper part 2 (CT and MR angiography, standard medical reporting, future perspectives) 94
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage 92
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 92
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR 91
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 90
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 90
Management of Intraventricular Gradient in Patients With Aortic Stenosis 89
A clinical and angiographic study of the XIENCE v everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial 89
Italian Society of Cardiology-Italian Society of Nephrology Consensus Document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal damage 88
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 88
ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement 88
Comparing the safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation: Twelve-month results from the RISPEVA study 86
Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review 86
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 85
B-type natriuretic peptide as biomarker of COVID-19 disease severity—a meta-analysis 84
Correction to: Acute advanced aortic stenosis 83
[Debate on dual pathway inhibition: Antiplatelet therapy in patients with peripheral artery disease: old but gold?] 82
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 82
Non-invasive myocardial work is reduced during transient acute coronary occlusion 82
Le valvulopatie 82
Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation 80
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 79
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 79
The five-year outcome of the transcatheter aortic valve replacement in the partner 2A study in patients with intermediate surgical risk-what is clear and what it is unclear 79
Recommendations in pre-procedural imaging assessment for transcatheter aortic valve implantation intervention: Italian Society of Cardiology (SIC)-Italian Society of Medical and Interventional Radiology (SIRM) position paper part 1 (Clinical Indication and Basic Technical Aspects, Heart Team, Role of Echocardiography) 79
The instantaneous wave-free ratio (iFR) for evaluation of non-culprit lesions in patients with acute coronary syndrome and multivessel disease 79
Late-Onset Ictal Asystole and Falls Related to Severe Coronary Artery Stenosis: A Case Report 78
Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: Expert opinion of the Italian Society of Cardiology and GISE 77
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 77
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 75
Acute advanced aortic stenosis 74
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 71
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 71
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 70
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 69
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 69
Assessment of Non-Invasive Measurements of Oxygen Saturation and Heart Rate with an Apple Smartwatch: Comparison with a Standard Pulse Oximeter 67
The Outbreak of COVID-19 in Italy: Fighting the Pandemic 64
Clinical and procedural outcomes of 5-French versus 6-French sheaths in transradial coronary interventions 60
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 59
Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome 59
Description and validation of TAVIApp: A novel mobile application for support of physicians in the management of aortic stenosis - Management of aortic stenosis with TAVIApp 59
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 58
Evaluation and percutaneous treatment of severely calcified coronary lesions 56
Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology 56
Will transcatheter aortic valve implantation represent the choice treatment for all patients who need a biological valve? 56
Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation 55
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy 54
Design of the PERSEO Registry on the management of patients treated with oral anticoagulants and coronary stent 53
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes 53
Angioplasty in chronic coronary syndromes after the ISCHEMIA trial: What's new? - The interventional cardiologist's point of view 53
Lipid-lowering therapy in patients with coronary artery disease undergoing percutaneous coronary interventions in Italy: an expert opinion paper of Interventional Cardiology Working Group of Italian Society of Cardiology 50
Delayed flow-mediated vasodilation and critical coronary stenosis 50
Climbing the hill of left main coronary artery revascularization: Percutaneous coronary intervention or coronary artery bypass graft? 50
L’eterno confronto tra by pass ed angioplastica nel paziente multivasale: i nuovi risultati dello studio Syntax II 49
Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine 49
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 47
Standard versus ultrasound‐guided cannulation of the femoral artery in patients undergoing invasive procedures: A meta‐analysis of randomized controlled trials 47
The Role of Circulating Biomarkers in Patients with Coronary Microvascular Disease 46
Therapy with RAS inhibitors during the COVID-19 pandemic 46
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 46
Transcatheter versus surgical aortic valve replacement in low-risk patients for the treatment of severe aortic stenosis 46
Reliability of instantaneous wave-free ratio (iFR) for the evaluation of left main coronary artery lesions 46
Molecular mechanisms of restenosis after percutaneous peripheral angioplasty and approach to endovascular therapy 45
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 44
Old unsolved problems: When and how to treat silent ischaemia 44
le complicanze cardiologiche 44
Functional and morphological cardiovascular alterations associated with neurofibromatosis 1 44
Are we ready for a gender-specific approach in interventional cardiology? 44
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor 44
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 43
Algorithm for diagnosis of infective endocarditis after transcatheter aortic valve replacement 43
Delayed sudden radial artery rupture after left transradial coronary catheterization a case report 43
Drug-eluting stent implantation in patients with acute coronary syndrome - The activity of platelets after inhibition and cardiovascular events: Optical Coherence Tomography (APICE OCT) study 42
Migration of a stent from left main and its retrieval from femoral artery: A case report 42
Focus on relevant aspects of 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation 42
Cardiovascular Prognosis in Patients with Peripheral Artery Disease and Approach to Therapy 41
Stadiazione del Rischio Cardiovascolare nel Diabete Mellito 41
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent 40
The effects of COVID-19 on general cardiology in Italy 40
MicroRNAs fingerprint of bicuspid aortic valve 39
Response to letter regarding, "administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome" 39
Vecchi problemi irrisolti. Come trattare l’ischemia silente 39
The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: Results of the SYNTAX II study 39
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry 38
The smartwatch detects ECG abnormalities typical of Brugada syndrome 38
The outlook of prognostic indicators for the Takotsubo syndrome 38
Totale 7.302
Categoria #
all - tutte 28.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 3 0 0 0
2021/2022523 0 0 4 0 0 0 12 0 193 65 119 130
2022/2023700 93 17 23 17 38 34 2 22 73 197 169 15
2023/2024535 19 63 108 21 29 14 17 54 8 28 103 71
2024/20253.168 159 220 40 35 167 141 366 180 255 375 1.001 229
2025/20263.215 553 574 615 521 865 87 0 0 0 0 0 0
Totale 8.148